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Introduction
Structural plasticity and reorganization of neuronal connections 
underpin many brain functions including memory, learning, and 
addiction. In neurons, polymerized actin is the major structural 
constituent of dendritic spines, specialized structures involved 
in synaptic communication. Regulation of the actin cytoskele-
ton  influences  filopodial  outgrowth,  novel  spine  production, 
and changes in spine morphology as well as spine loss (Fischer 
et al., 2000; Dillon and Goda, 2005). Structural reorganization 
of spine morphology is an ongoing dynamic process sensitive   
to  Ca
2+  influx  through  glutamatergic  N-methyl-d-aspartate 
(NMDA) receptors and voltage-operated Ca
2+ channels (Fischer 
et al., 2000; Saneyoshi et al., 2010). Longer-term consolidation 
of structural changes occurs through altered gene expression and 
insertion of novel proteins into the synaptic spine (West et al., 
2002;  Lamprecht  and  LeDoux,  2004;  Greer  and  Greenberg, 
2008; McClung and Nestler, 2008).
microRNAs (miRs) are endogenous noncoding RNA mole-
cules (Lee at al., 1993; Wightman et al., 1993; Bartel, 2004) 
that mediate posttranscriptional regulation of gene expression 
by targeting the 3 untranslated region (UTR; 3-UTR) of spe-
cific mRNA sequences and by repressing their translation into 
proteins (Bartel, 2004; Winter et al., 2009). miRs exhibit devel-
opmental regulation, tissue specificity, and differential expression 
in specialized subcellular compartments (Miska et al., 2004; 
Sempere et al., 2004; Kosik, 2006; Christensen and Schratt, 
2009; Fineberg et al., 2009). In neurons, several miRs are specifi-
cally enriched in dendritic spines where they fine tune localized 
protein synthesis (Schratt et al., 2006; Schratt, 2009; Siegel et al., 
2009). Here, miRs appear to regulate dendritic spine morpho-
genesis (Wayman et al., 2008; Siegel et al., 2009; Edbauer et al., 
2010), spine structure (Schratt et al., 2006; Siegel et al., 2009),   
P
revious studies have demonstrated that microribo­
nucleic acids (miRs) are key regulators of protein 
expression  in  the  brain  and  modulate  dendritic   
spine morphology and synaptic activity. To identify novel 
miRs involved in neuronal plasticity, we exposed adult 
mice to chronic treatments with nicotine, cocaine, or am­
phetamine, which are psychoactive drugs that induce   
well­documented neuroadaptations. We observed brain 
region– and drug­specific changes in miR expression   
levels and identified miR­29a/b as regulators of synaptic 
morphology. In vitro imaging experiments indicated that 
miR­29a/b  reduce  mushroom­shaped  dendritic  spines   
on hippocampal neurons with a concomitant increase in   
filopodial­like outgrowths, suggesting an effect on synapse 
formation via actin cytoskeleton remodeling. We identi­
fied Arpc3, a component of the ARP2/3 actin nucleation 
complex, as a bona fide target for down­regulation by 
miR­29a/b. This work provides evidence that targeting of 
Arpc3  by  miR­29a/b  fine  tunes  structural  plasticity  by 
regulating actin network branching in mature and devel­
oping spines.
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be expressed as a single transcriptional unit (Lee et al., 2002; 
Kim et al., 2009). According to these criteria, 32 miRs were se-
lected, and changes in expression levels between brain areas and 
drug treatments were quantified using custom-made real-time 
PCR plates (Fig. 1). The drug and brain region specificity of miR 
up-regulation is outlined in Fig. S2, with several miRs being tar-
geted by two or more drug treatments. In particular, we identi-
fied consistent up-regulation of the miR-29a/b and miR-182/183 
clusters  in  most  brain  regions.  In  contrast,  the  miR-200/429 
cluster appeared to be more heavily targeted in the ventral mid-
brain and subcortical limbic forebrain (Figs. 1 and S2). Of the 
single transcripts, miR-680 and miR-190b also appeared to be 
consistently up-regulated in most of the areas assessed. There-
fore, these 32 miRs were selected for further study.
Activity-dependent up-regulation of miRs 
during synaptogenesis
The formation of synaptic contacts during development demon-
strates a high level of plasticity, as new spines are formed and 
then either removed or consolidated according to the strength of 
connections made (Dunaevsky et al., 1999; Yang et al., 2009). As 
we had postulated that miRs targeted during periods of drug- 
induced neuroplasticity were also likely to be regulators of more 
general neuroplastic changes, we next examined the expression 
levels of the selected 32 miRs in an in vitro model of synapto-
genesis (Grabrucker et al., 2009). Expression levels of miRs were 
therefore measured in primary cultures of mouse hippocampal 
neurons at 7 d in vitro (DIV), a point at which the neurons are rel-
atively immature. miR levels were then measured in the same 
cultures at 14 DIV, when mature synapses are being formed, and 
synaptic connectivity has been consolidated (Fig. 2 B; Ogura   
et al., 1987; Bacci et al., 1999). An initial screen demonstrated that 
a small portion of the previously identified 32 miRs was also up-
regulated in this in vitro model system (unpublished data). Quan-
tification, via real-time PCR, demonstrated that the miR cluster 
containing  miR-29a/b  was  up-regulated  around  3.5–4.2  fold, 
whereas the miR-182/183 cluster was up-regulated 13.6–17.6 fold 
(Fig. 2 A). In contrast, miR-680 and miR-190b were not sig-
nificantly up-regulated over this time period and so appeared less 
likely to be actively involved in the process of synaptogenesis.
Neuronal  activity  regulates  gene  transcription  via   
frequency- and amplitude-encoded Ca
2+ signals (Greer and 
Greenberg, 2008). To determine whether up-regulation of miR-
29a/b and miR-182/183 was similarly activity dependent, neuronal 
activity in hippocampal neurons was stimulated via the addition of 
picrotoxin  (PTx;  a  GABAA  receptor  antagonist  that  enhances   
activity by blocking the inhibitory influence of GABAergic inter-
neurons present in the culture; Bacci et al., 1999). Drug additions 
were made at 7 or 9 DIV, and miR levels were examined after a 
further 48 h. The ability of PTx to enhance Ca
2+ activity in the 
mouse hippocampal cultures was first confirmed using single-cell 
imaging of fura-4f–loaded neurons (Fig. 2 B). Treatment with   
50 µM PTx induced up-regulation of both sets of miR clusters at 
9 DIV. The magnitude of responses was broadly similar in both 
sets of clusters, ranging from increases of 60 ± 7 to 109 ± 48% for 
miR-29a and miR-29b (P = 0.0001 and 0.073, respectively; n = 3) 
and 74 ± 20% for miR-182 and 80 ± 39% for miR-183 (P = 0.0008 
and synaptic physiology (Edbauer et al., 2010). miR-134 reduces 
spine size by targeting the synaptic protein LIMPK1, a kinase 
that enhances actin polymerization via inactivation of the actin 
depolymerization factor cofilin (Schratt et al., 2006). Similarly, 
miR-138 modulates spine size by targeting APT1 and activat-
ing the RhoA pathway (Schratt, 2009; Siegel et al., 2009). Im-
portantly, levels of both miR-134 and miR-138 are regulated by 
neuronal activity, thereby demonstrating a feedback mechanism 
between  synaptic  signaling,  miR  expression,  localized  regu-
lation of translation, and spine morphology.
Despite these examples, the role of miRs in the regulation of 
synaptic structure and function, and hence synaptic plasticity, re-
mains poorly understood. In this study, we have used chronic treat-
ments with psychostimulants (nicotine, cocaine, and amphetamine) 
to induce widespread neuroplastic changes in adult mouse brain. 
We have then screened for individual miRs and miR clusters regu-
lated during these treatments, as we postulated that miRs targeted 
during periods of drug-induced neuroplasticity were also likely to 
have a physiological role in the maintenance of synaptic connec-
tions. Via cross-referencing with a second, more focused, screen of 
miR regulation during periods of synaptogenesis in cultured neu-
rons, we now identify the miR-29a/b cluster as an important regu-
lator of dendritic spine morphology and synaptic connectivity. 
Furthermore, we demonstrate that miR-29a/b directly target the 
mRNA encoding for Arpc3, a subunit of the ARP2/3 actin nucle-
ation complex (Goley and Welch, 2006). This complex is required 
for the production of branched actin filaments and is involved in 
dendritic spine morphogenesis (Hotulainen et al., 2009). We sug-
gest that miR-29a/b fine tune structural plasticity via regulating the 
sensitivity of ARP2/3 to remodeling cues in the spine.
Results
Regulation of miRs during neuroplasticity 
in vivo
Chronic treatments with psychostimulants produce substantial 
neuroplastic changes in the brain (Robinson and Kolb, 2004; 
Tang and Dani, 2009). Recent data now suggest that altered 
miR levels contribute to the plastic changes underlying addic-
tive  behaviors  (Chandrasekar  and  Dreyer,  2009;  Hollander   
et al., 2010; Im et al., 2010). To identify miRs involved in psycho-
stimulant-induced neuroplasticity, C57BL6 mice (four to five 
per group) were exposed to saline, 1 mg/kg nicotine (tartrate), 
10 mg/kg cocaine (hydrochloride), or 5 mg/kg amphetamine 
(sulfate) for 5 d (one injection/day) and sacrificed 4 h after the 
last  injection.  For  each  animal,  the  hippocampus,  prefrontal 
cortex, subcortical limbic forebrain, and ventral midbrain were 
dissected and total RNA (including small RNAs) extracted. Our 
initial screen, performed by pooling samples between animals 
that were exposed to the same treatment (but keeping areas sep-
arated), demonstrated that chronic drug exposure affected the 
miR transcriptome in a drug- and region-specific manner (Fig. S1). 
Potential  candidates  for  further  investigation  were  identified   
according to the following criteria: (a) miRs that were consistently 
up-regulated  by  different  psychoactive  drugs,  (b)  miRs  that 
were consistently up-regulated across different brain areas, and 
(c) genetically clustered up-regulated miRs that were likely to 891 miR29a/b effect on spine morphology • Lippi et al.
2004; McClung and Nestler, 2008). To determine whether the 
identified miRs altered synaptic spine structure, primary hippo-
campal neurons were cotransfected with a plasma membrane–
targeted GFP construct (GFP-MEM) plus oligonucleotides for 
miR-29a, -29b, -182, or -183, and spine morphology was exam-
ined using confocal microscopy. This approach was validated 
using a dsRed-based reporter construct with miR seed regions 
cloned into the 3-UTR (Fig. S4). Hippocampal neurons, which 
were transfected at 9 DIV and imaged at 14 DIV, demonstrated 
a mixed phenotype of dendritic protrusions (Fig. 3, A and B). 
These were characterized as either filopodia (which lacked any 
spine head enlargement) or subclassed into long, mushroom, or 
stubby  spine  categories  (Fig.  3  B;  Hotulainen  et  al.,  2009). 
Mushroom-shaped spines were, by far, the most prevalent spine 
shape observed, and, broadly speaking, at 14 DIV, these and   
filopodia were present in approximately equal numbers. Cotrans-
fection of neurons with 10 nM miR-29a or -29b altered the den-
dritic  phenotype  measure  at  14  DIV.  miR-29a  reduced  the 
number of mushroom spines from 3.4 ± 0.2 to 1.0 ± 0.3 per   
10-µm dendritic length (P < 0.001 compared with scrambled 
control; n = 26), with a concomitant increase in the number of 
filopodia (2.6 ± 0.4 to 5.1 ± 0.5 per 10-µm dendritic length;   
P < 0.001; n = 26; Fig. 3 C). However, the total number of protru-
sions remained unchanged (Fig. 2, C and D). miR-29b produced 
similar results, with a 2.9 ± 1.3 to 1.3 ± 0.2 decrease in the number 
and 0.0234, respectively; n = 3). In contrast, PTx treatment did 
not enhance expression at 11 DIV above the already raised levels. 
At this point, basal neuronal activity (Fig. 2 B) in the absence of 
PTx appeared capable of maintaining miR levels. To investigate 
this further, basal Ca
2+ activity in the cultures was inhibited via 
the addition of the NMDA receptor antagonist AP5. This pro-
duced a marked reduction in miR-29a and -29b as measured at   
11 DIV (61.8 ± 0.5 and 58.4 ± 2.6% reductions, P = 0.0001 and 
0.0025, respectively; n = 3; Fig. 2, C and D). In comparison, ex-
pression levels of miR-182 and -183 were only partially inhibited 
by AP5, and, as a result of the greater degree of variability be-
tween experiments, these decreases were not significant (48 ± 19 
and 20 ± 24% reductions; n = 4; Fig. 2, E and F). Expression of 
both sets of miR clusters was also reduced by the addition of   
10 µM PD98059, suggesting an involvement of MEK1/extracel-
lular signal-regulated kinase, which was most probably acting 
downstream of NMDA receptor–mediated Ca
2+ entry (53 ± 5% 
reduction for miR-29a, P = 0.0004; 27 ± 3% reduction for miR-29b, 
P = 0.0025; 37 ± 22% reduction for miR-182, P = 0.19; and   
38 ± 35% reduction for miR-183, P = 0.28; n = 4; Fig. 2, C–F).
Effect of candidate miRs on synaptic 
structure and function
Activity-dependent remodeling of synaptic structure plays an 
import  role  in  neuronal  plasticity  (Lamprecht  and  LeDoux, 
Figure 1.  In vivo screening for miRs involved in neuroplasticity. (A–D) Adult C57BL6 mice (four to five per group) were treated with a single i.p. injection 
of saline, 1 mg/kg nicotine, 10 mg/kg cocaine, or 5 mg/kg amphetamine once a day for 5 d. 4 h after the final injection, brain regions were dissected, 
and miRs were extracted. Changes in expression levels of a subset of 32 miRs were analyzed in custom-made 96-well miR arrays (TaqMan). Four areas 
that receive dopaminergic inputs from the ventral tegmental area were assessed, namely the ventral midbrain (A), subcortical limbic forebrain (B), prefrontal 
cortex (C), and hippocampus (D). Dotted lines represent the threshold of physiological relevance with a >1.6-fold up-regulation. Data represent the mean 
value ± SEM from four to five animals/group, and comparisons were performed using an unpaired t test. Ctrl, control; +, 0.1 < P > 0.05; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.JCB • VOLUME 194 • NUMBER 6 • 2011   892
data suggested that miR-29a/b expression prevented the conver-
sion of dendritic filopodia to a mature spine phenotype.
To determine the effects on synaptic transmission, minia-
ture excitatory postsynaptic currents (mEPSCs) were mea-
sured in miR-29a– and -29b–transfected primary hippocampal   
neurons (Fig. 4 A). Neuronal cultures were first treated with   
0.5 µM tetrodotoxin (TTx) to block spontaneous evoked network 
glutamatergic transmission (Fig. 4 B, top trace). Under these 
conditions, miR-29a and -29b expression reduced the fre-
quency of mEPSCs from 7.05 ± 2.3 to 1.4 ± 0.4 and 2.4 ± 0.8 s
-1, 
respectively  (P  <  0.05;  n  =  5–7),  without  altering  mEPSC   
of mushroom spines, and a 2.6 ± 0.3 to 4.6 ± 0.4 increase in filo-
podia (P < 0.001, n = 32). In contrast, neither miR-182 nor -183 
affected spine number (Fig. 3, E and F), although miR-183 did 
cause a modest decrease in filopodia (3.0 ± 0.3 to 1.8 ± 0.2, n = 48 
and 23, respectively; P < 0.001; Fig. 3 F). Finally, the effect of the 
miR-29b oligonucleotide could be mimicked by transfection of a 
miR-29b expression plasmid (pEZX; GeneCopoeia). Transfected 
neurons were identified via the expression of a GFP reporter   
integral to the plasmid. However, as GFP expression was low com-
pared with the EGFP-MEM, neuronal morphology was ex-
amined via coexpression with tdTomato (Fig. S3). Overall, these   
Figure 2.  Activity-dependent miR up-regulation. Primary cultures of C57BL6 mouse hippocampal neurons were grown for up to 14 DIV. (A) miRs were 
extracted from primary neuronal cultures at 7 and 14 DIV. Changes in the levels of 32 selected miRs were then examined via miR assay (TaqMan; data 
represent the mean ± SEM from three experiments; P = 0.0359 for 29a, 0.0224 for 29b, 0.0273 for 182, and 0.0388 for 183 using an unpaired t test, 
whereas none of the other selected miRs demonstrated significant up-regulation). (B) Primary neuronal cultures at 9, 11, and 14 DIV were loaded with fura-4f,   
and intracellular Ca
2+ transients were imaged. Data are representative traces of network Ca
2+ activity either in control (ctrl; untreated) neurons or where 
50 µM PTx had been added to the same neurons. (C–F) Clusters containing either miR-29a/b or miR-182/183 demonstrated activity-dependent regulation 
between 9 and 11 DIV. Enhancement of neuronal activity via treatment with 50 µM PTx from 7–9 DIV induced up-regulation of miR-29a by 60 ± 7.1%   
(P < 0.0001), 29b by 109 ± 48% (P = 0.0073), 182 by 74 ± 20%, (P = 0.0008), and 183 by 80 ± 39% (P = 0.0234). Addition of PTx from 9 and 11 
DIV did not enhance miRs levels compared with control. Treatment with 10 µM AP5 between 9 and 11 DIV reduced the miR-29a levels by 61.8 ± 0.5% 
(P < 0.0001 vs. control) and 29b levels by 58.4 ± 2.6% (P = 0.0025 vs. control). The reduction is present also in miR-182/183 although not significant.   
10 µM PD98059 also reduces the spontaneous increase of miR-29a (53 ± 5.1% of the control; P = 0.0004) and 29b (27 ± 2.7% of the control; P = 0.0025), 
but, again, the effect is not significant on miR-182/183. All miR levels are relative to the housekeeping sno202. Data in panels C–F represent the mean ± 
SEM from three to four independent experiments, and comparisons were performed using an unpaired t test. (A and C–F) +, 0.1 < P > 0.05; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.893 miR29a/b effect on spine morphology • Lippi et al.
Figure 3.  Effect of miRs on spine morphology. Primary cultures of hippocampal neurons were cotransfected with EGFP-MEM plus miR oligonucleotides at 
9 DIV, and effects on neuronal structure were investigated at 14–15 DIV using confocal microscopy. (A) A representative image of a hippocampal dendrite 
at 14 DIV transfected with EGFP-MEM. Bar, 5 µm. (B) Sample images demonstrating the classification of dendritic filopodia and thin, mushroom, or stubby 
spines in EGFP-MEM–transfected neurons. Bar, 1 µm. (C–F) Representative images of dendritic regions of neurons transfected with miR-29a (C), miR-29b 
(D), miR-182 (E), or miR-183 (F). Data represent the mean ± SEM number of protrusions per 10-µm dendritic length for 23–48 transfected neurons. Both miR-29a 
and -29b enhanced the number of filopodia and reduced the number of mushroom spines (P < 0.001). **, P < 0.01; ***, P < 0.001. Bar, 5 µm.
amplitude or decay kinetics (Fig. 4, C–E). The mEPSC amplitude 
was 45.4 ± 4.7 pA under control conditions and 39.6 ± 6.1 
and 40.4 ± 4.7 pA in miR-29a and miR-29b cells, respectively. 
Decay rates were 6.4 ± 0.7 ms for control cells, 3.7 ± 0.4 for 
miR-29a cells, and 5.6 ± 0.4 ms for miR-29b cells (n = 5–7). 
This supports the notion that miR-29a/b expression reduces the JCB • VOLUME 194 • NUMBER 6 • 2011   894
Using  two  different  target  prediction  software  packages   
(TargetScan  and  miRBase;  Lewis  et  al.,  2005),  we  selected   
24 putative mRNAs that encoded proteins capable of regulating 
neuronal morphology and that demonstrated 3-UTR comple-
mentarity to miR-29a/b (Fig. S4 A). miRs can inhibit protein 
expression  by  repressing  mRNA  translation  or  promoting 
mRNA destabilization/degradation (Lim et al., 2005; Bartel, 
2009), and recent work suggests that the predominant mecha-
nism of action involves a reduction in levels of target mRNA 
(Guo et al., 2010). Using BACE1 mRNA, a previously identi-
fied miR-29 target, as a positive control (Hébert et al., 2008), 
we observed that transfection of miR-29b into primary hippo-
campal neurons also reduced mRNA levels for the following: 
number of synaptic connections via a decrease in the number of 
mushroom-shaped dendritic spines. However, the lack of effect 
on mEPSC amplitudes and kinetics suggests that the postsynaptic 
machinery, where present, was unaffected by miR-29a or -29b 
(Edbauer et al., 2010). In support of this, network Ca
2+ tran-
sients, induced by the addition of 50 µM PTx, were unaffected 
by miR-29a/b expression (Fig. S3).
Down-regulation of Arpc3 mRNA mimics 
the miR-29a/b phenotype
The miR-29a/b expression phenotype suggested potential gene 
targets associated with remodeling of the actin cytoskeleton 
(e.g., Rho family–associated proteins or actin nucleation factors). 
Figure 4.  Expression of miR-29a/b reduces 
the frequency of mEPSCs. Primary cultures of 
hippocampal neurons were cotransfected with 
EGFP-MEM plus miR oligonucleotides at 9 DIV, 
and effects on synaptic activity were investi-
gated at 14–15 DIV. (A, top left) Application 
of 0.5 µM TTx suppresses spontaneous activity 
leaving only mEPSCs. (top right) Basal level of 
mEPSC activity in neuron-expressing miR-Scr. 
(bottom) Neurons expressing miR-29a or -29b 
show reduced mEPSC activity (all recordings 
were performed in the presence of 0.5 µM 
TTx).  (B)  Representative  averaged  mEPSCs 
from neurons containing either miR-Scr, miR-
29a, or miR-29b. (C) Relative cumulative fre-
quency (cum rel) histograms for amplitude and 
decay distributions. There is no significant dif-
ference between miR-Scr and miR expression 
using the Kolmogorov–Smirnov test. (D) Histo-
grams for amplitude and decay distributions. 
(E) Mean ± SEM values for amplitude, decay,   
and  frequency  from  neurons  expressing  miR-
Scr (green), miR-29b (red), or miR-29a (blue) 
for 5–7 cells (the actual numbers of cells are   
indicated  within  the  bars  on  left  graph).   
*, P < 0.05 using an analysis of variance with 
a post-hoc test.895 miR29a/b effect on spine morphology • Lippi et al.
Figure 5.  Effect of siRNA on spine morphology. (A–I) Primary cultures of hippocampal neurons were cotransfected with EGFP-MEM plus siRNA oligonucleo-
tides at 9 DIV, and effects on neuronal structure were investigated at 14–15 DIV using confocal microscopy. Data are representative images plus graphs 
demonstrating the mean ± SEM number of protrusions for Scr control siRNA and siRNA targeted against ArhGAP28 (n = 27; A), Arpc3 (**, P = 0.008; 
***, P < 0.001; n = 15; B), Camk2b (*, P = 0.02; n = 12; C), Coro6 (*, P = 0.048; n = 13; D), Dnm3 (n = 10; E), Gprin1 (n = 11; F), Lasp1 (n = 8; G), 
Ophn1 (**, P = 0.001; n = 21; H), and RapGEFL1 (**, P = 0.001; n = 12; I). Bars, 5 µm.JCB • VOLUME 194 • NUMBER 6 • 2011   896
Figure 6.  Targeting of Arpc3 by miR-29a/b. (A, top) Predicted interaction between the Arpc3 3-UTR MRE and the miR-29a microseed using MicroCosm 
analysis. (bottom) A comparison of the Arpc3 MRE in different species demonstrates a high degree of conservation both in the seed region and in the com-
pensatory site. mmu, Mus Musculus. (B) Plasmid overexpression of miR-29a and -29b in N2a cells results in significant down-regulation of Arpc3 mRNA levels 
(27 ± 9%, P = 0.048 and 42 ± 3.5%, P = 0.0003, respectively; data represent the mean ± SEM from three independent experiments, and comparisons were   
performed using an unpaired t test). Levels were assessed by Universal ProbeLibrary assay (TaqMan) after FACS sorting for GFP-expressing cells. (C) Concen-
tration response effect of miR-29a and -29b oligonucleotides and miR-29a and -29b antagonists on pGL3-mArpc3 in HEK-293 cells. 10 and 50 nM miR-29a and 
-29b oligonucleotides increasingly inhibited luciferase activity (P = 0.005 and 0.004, respectively, at 10 nM, and P = 0.002 and P = 0.0004, respectively, at   
50 nM; n = 10). In contrast, 1 nM oligonucleotide did not produce any significant reduction. 50 nM miR-182 was used as a control (light gray bar). Transfection of   897 miR29a/b effect on spine morphology • Lippi et al.
ArhGAP28, Arpc3, Camk2b, Coro6, Daam1, Dnm3, Fez2, Gprin1, 
Lasp1, Ophn1, Pcdha1, RapGEFL1, and Rhobtb1 (Fig. S4 A).
Next, candidate proteins were subjected to siRNA-mediated 
knockdown. ArhGAP28, Arpc3, Camk2b, Coro6, Dnm3, Gprin1, 
Lasp1, Ophn1, and RapGEFL1 were selected, as these appeared 
most likely to regulate synaptic morphology. Validated siRNA 
oligonucleotides  (Fig.  S4  B)  were  cotransfected  with  GFP-
MEM into primary hippocampal neurons at 9 DIV, and images 
of dendritic morphology were captured at 14 DIV. Dendritic 
protrusions were then scored as described under the previous 
subheading. Of the selected proteins, only knockdown of Arpc3 
produced a phenotype similar to miR-29a/b expression (Fig. 5). 
Thus, in Arpc3 siRNA–treated neurons, there was a reduction 
of 2.2 ± 0.2 to 1.4 ± 0.2 per 10-µm dendritic length in the num-
ber of mushroom spines (n = 35 and 15, respectively; P = 0.008) 
and an increase of 4.2 ± 0.4 to 7.1 ± 0.8 per 10-µm dendritic 
length  in  filopodia  (P  <  0.001;  Fig.  5  B).  Knockdown  of 
Camk2b, Ophn1, and RapGEFL1 also increased the number of 
filopodia but had no significant effect on the number of mush-
room spines (Fig. 5, C, H, and I).
Arpc3 mRNA and protein expression are 
targeted by miR-29a/b
To determine whether Arpc3 was a bona fide target for miR-29a/
b–mediated down-regulation, we first investigated the predicted 
interaction between miR-29a/b with the 3-UTR of Arpc3. The 
alignment  for  mouse  Arpc3,  according  to  the  MicroCosm   
Targets database, is illustrated in Fig. 6 A. The miR-responsive ele-
ment (MRE) is highly conserved throughout species, as shown 
by the 30-way Multiz Alignment software (University of Cali-
fornia, Santa Cruz genome browser; Fig. 6 A). To confirm that 
Arpc3 is a genuine target of miR-29a/b, mouse N2a cells were 
transfected with pEZX plasmid expression clones for miR-29a 
or -29b (see Effect of candidate miRs on synaptic structure and 
function). The coexpression of GFP from the pEZX vector en-
abled selection of miR-29a– or -29b–overexpressing cells only. 
As demonstrated in Fig. 6 B, the Arpc3 transcript was signifi-
cantly down-regulated by both miR-29a and -29b (27 ± 9%,   
P = 0.048; 42 ± 4%, P = 0.0003; n = 3; Fig. 6 B). In these experi-
ments, selected cells demonstrated an increase in miR levels of 
around 10–25 fold, which appeared comparable with the method 
whereby the miR oligonucleotide was coexpressed with EGFP-
MEM (Fig. S5 B).
Next, we cloned the 3-UTR of Arpc3 from either human 
(pGL3-hsArpc3) or mouse (pGL3-mmArpc3) downstream of 
a  luciferase-coding  sequence  (pGL3–multiple  cloning  site). 
The constructs were overexpressed in HEK-293 cells, and   
luciferase chemiluminescence was detected in control (trans-
fected with the miR-Scr oligonucleotide) or miR-29a or -29b 
oligonucleotide–transfected cells (50 nM). In addition, miR-182 
was selected as a further control condition. miR-29a and -29b 
selectively inhibited pGL3-mmArpc3 and pGL3-hsArpc3 ex-
pression,  thereby  demonstrating  a  direct  targeting  effect  of 
these miRs on Arpc3 expression (pGL3-mmArpc3 29a: 29 ± 
3.2%, P = 0.0018; 29b: 33 ± 3.5%, P = 0.0004; pGL3-hsArpc3 
29a: 22 ± 3.4%, P = 0.0012; 29b: 30 ± 3.4%, P < 0.0001;   
n = 16; Fig. S5 C).
To further characterize the posttranscriptional regulation 
of the pGL3-mArpc3 construct, we examined the concentration 
relationship of miR-29a and -29b oligonucleotides on luciferase 
activity in HEK-293 cells. The greatest level of inhibition was 
observed with 50 nM oligonucleotide, with 10 nM also produc-
ing a significant inhibition (Fig. 6 C). In contrast, the effect of   
1 nM oligonucleotide was not significantly different from con-
trol.  Quantitative  real-time  PCR  experiments  suggested  that 
HEK-293  cells  expressed  significant  endogenous  levels  of   
miR-29a/b. To determine whether these endogenous miRs were sup-
pressing  luciferase  activity,  HEK-293  cells  were  transfected 
with increasing concentrations of miR antagonists against   
either miR-29a or -29b. As demonstrated in Fig. 6 C, increasing 
the miR antagonist concentration (ranging from 2.5 to 100 nM) 
produced a progressive increase in luciferase activity (maxi-
mum effect obtained with miR-29a/b antagonist at 100 nM; 
35.8 ± 3.4% increase, P < 0.0001; n = 8; Fig. 6 C). The specific-
ity of this effect was demonstrated by inducing point mutations 
in two nucleotides in the mArpc3 seed region (Fig. 6 A, red   
arrowheads). This mutated luciferase construct was insensitive 
to miR-29a or -29b or miR-29a or -29b antagonist oligonucleo-
tides (Fig. 6 C).
The aforementioned data demonstrate that Arpc3 levels 
are directly regulated by the targeting of miR-29a or -29b to the 
identified 3-UTR MRE. To demonstrate regulation of Arpc3 
levels in situ, 50 nM miR-29b or 100 nM miR-29b antagonist 
was transfected into hippocampal neurons, and protein expres-
sion levels were examined (Fig. 6 D). Transfection with miR-29b 
oligonucleotides  reduced  Arpc3  protein  levels  by  25  ±  2%   
(P = 0.041; n = 3). In contrast, transfection with the miR-29b   
antagonist increased expression levels by 28 ± 10% (P = 0.040;   
n = 3). Protein levels of Arp3, a different subunit of the Arp2/3 
actin nucleation complex, were unchanged by these treatments 
(Fig. 6 D). Of note, down-regulation of Arpc3 protein levels by 
miR-29b was only moderately less efficient than down-regulation 
by Arpc3-specific siRNA (Fig. S5 D). Finally, as data in Fig. 2 
indicated that miR-29a/b levels increased between 7 and 14 DIV, 
25 or 100 nM miR-29a and -29b antagonists increased luciferase activity (P = 0.0004 and 0.0002, respectively, at 100 nM, and P = 0.008 for 29b at 25 nM; 
n = 10). A double point mutation in two nucleotides of the MRE in the Arpc3 3-UTR (A, red arrowheads) abolishes the regulatory effect of both miR oligo-
nucleotides (50 nM) and miR antagonists (100 nM; black bars) without altering basal luciferase activity. The dotted lines represent the control value (1) to help 
visualize changes in luciferase activity upon up-regulation or inhibition of miR-29a/b. Data are mean ± SEM, and analysis was performed using an unpaired 
t test. (D) Protein levels of Arpc3 are down-regulated by miR-29b in primary mouse hippocampal neurons. Transfection of 50 nM miR-29b oligonucleotides   
results in a significant down-regulation of Arpc3 protein levels, as measured via Western Blotting (WB; 25 ± 2% decrease; P = 0.04; n = 3). In contrast, 100 nM   
miR-29b antagonist increased expression levels by 28 ± 9.6 (P = 0.04; n = 3). In comparison, Arp3, another component of the Arp2/3 complex, was un-
affected by pre–miR-29b or miR-29b antagonist. Data represent the mean ± SEM, and comparisons were performed using an unpaired t test. MM, molecular 
mass. (E) Arpc3 levels in primary hippocampal neurons decrease between 7 (P = 0.05) and 14 (P = 0.005) DIV (47 ± 13 and 67 ± 4% decrease for mRNA 
and protein, P = 0.05 aand 0.005, respectively; n = 3 each; data represent the mean ± SEM). (B–E) *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 7.  miR-29a and -29b regulate sensitivity to neuroplastic changes. (A and B) Primary cultures of hippocampal neurons at 9 DIV were transfected 
with EGFP-MEM ± Arpc3 in which the miR-29 seed region contained two point mutations (mutArpc3) plus siRNA oligonucleotides. Effects on neuronal 
structure were investigated at 14–15 DIV using confocal microscopy. Data are representative images plus graphs demonstrating the mean ± SEM number 
of protrusions for miR-Scr and miR-29b for EGFP-MEM alone (A) or EGFP-MEM plus mutArpc3 (B). (A) As demonstrated previously, miR-29b enhances the 
number of filopodia (P = 0.01) and reduces the number of mushroom spines (P < 0.001; n = 12). (B) miR-29b did not alter dendritic morphology in neu-
rons expressing mutArpc3 (n = 12). (C–E) miR-29a antagonist reduces spine volume changes induced by TTx. Dendritic regions of hippocampal neurons 
cotransfected with EGFP-MEM plus 50 nM miR-Scr or miR-29a antagonist were imaged via confocal microscopy at 14 DIV and then again after 24 h in the 
presence or absence of 0.5 µM TTx. Changes in spine volume were calculated from 3D volume–rendered images. (C) Representative dendritic images for 
Scr antagonist and miR-29a antagonist neurons before and after a 24-h period under control (Ctrl) conditions or in neurons treated with TTx. Note the loss 
of spine structure in Scr antagonist after 24 h in the presence of TTx (middle). (D) Expression of miR-29a antagonist did not alter spine volume measured 
at 14 DIV (data from 200 and 170 spines; not depicted). Treatment with TTx for 24 h reduced spine volume in Scr antagonist neurons by 43.5 ± 6.9% 899 miR29a/b effect on spine morphology • Lippi et al.
enhances spine motility (Korkotian and Segal, 2001; Richards 
et al., 2005); however, longer-term inhibition of synaptic trans-
mission alters spine morphology (Papa and Segal, 1996). Our 
data suggest that miR-29a/b may fine tune the sensitivity of   
mature synaptic spines to neuroplastic cues by regulating the   
expression of Arpc3 and hence the functioning of the ARP2/3   
actin nucleation complex (Gournier et al., 2001). To investigate 
this hypothesis in more detail, we set up a protocol to measure 
changes in the volume of spines over a 24-h period. 3D volume–
rendered images were created from GFP-MEM–expressing pri-
mary hippocampal neurons at 14 DIV. Changes in spine volume 
were then calculated by imaging the same dendritic regions   
after 24 h in culture medium alone or in culture medium in which 
neurotransmission was inhibited by the addition of 0.5 µM TTx 
(Fig. 7 C). Under control conditions, spines increased in vol-
ume by 1.4 ± 0.1 fold over the 24-h period, indicating that the 
process of spine morphogenesis was ongoing. In these cultures, 
average spine volume was not altered by the presence of 50 nM 
miR-29a antagonist (0.95 ± 0.07 µm
3 for miR-Scr and 0.84 ± 
0.06 µm
3 for miR-29a antagonist, with data from 200 and 170 
spines, respectively, and measured at 14 DIV in non-TTx–treated 
cultures;  Siegel  et  al.,  2009).  In  control  neurons  containing   
50 nM Scr antagonist, treatment with TTx for 24 h reduced spine 
volume by 43.5 ± 6.9% (89–104 spines from four experiments; 
P = 0.002). In contrast, neurons containing miR-29a antagonist 
were much less sensitive to the loss of synaptic transmission. 
Thus, TTx treatment reduced spine volume only by 25.2 ± 
16.9% over the same 24-h period (55–111 spines from four ex-
periments; NS from control miR-29a antagonist neurons; Fig. 7, 
C and D). These data suggest that, in the absence of miR-29a, 
mature neurons are less sensitive to morphological changes in-
duced by loss of synaptic connectivity. The ability of the miR-29a 
antagonist to inhibit miR-29a in primary hippocampal neurons 
was validated using a dsRed sensor (Siegel et al., 2009) contain-
ing the miR-29a seed region in the 3-UTR (see Materials and 
methods; Fig. S4).
Contextual fear conditioning induces up-
regulation of miR-29a/b in the hippocampus
A physiological form of hippocampal spine remodeling is the 
observed increase in spine density that is rapidly induced by 
several forms of learning (Leuner et al., 2003; Knafo et al., 
2004; Restivo et al., 2009). Contextual fear conditioning is a 
hippocampus-dependent learning test that consists in the asso-
ciation of a brief electrical shock with the context in which the 
shock is administered. This type of learning depends on both 
the formation of dendritic spines (Restivo et al., 2009) and actin 
we investigated whether this increase correlated with a decrease 
in Arpc3 in these cultures. As demonstrated in Fig. 6 E, both 
Arpc3 mRNA and protein levels decreased between 7 and 14 DIV 
(47 ± 13 and 67 ± 4% decrease for mRNA and protein, respec-
tively; P = 0.05 and 0.0053) relative to the housekeeping gene 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Rescue of the miR phenotype via  
mutated Arpc3
Arpc3 is a component of the seven-protein ARP2/3 actin nucle-
ation complex, responsible for initiating branching in actin fila-
ments (Goley and Welch, 2006). Previous work has demonstrated 
the importance of this complex for the conversion of dendritic 
filopodia to a mature spine phenotype (Hotulainen et al., 2009). 
Our data suggest that down-regulation of Arpc3 may be respon-
sible for the increased filopodia to spine ratio observed in re-
sponse to miR-29a/b. To examine this further, we created a 
construct encoding for the full mRNA of mouse Arpc3 contain-
ing the same two point mutations in the MRE as used in the   
luciferase assay mentioned in the previous section (Fig. 6 A). 
This  mutated  construct  (mutArpc3)  was  cotransfected  with 
GFP-MEM and either miR-Scr or miR-29b into primary hippo-
campal  neurons,  and  effects  on  dendritic  morphology  were 
measured. As described in Fig. 3 D, miR-29b increased the 
number of filopodia present along a 10-µm dendritic length, 
with a concomitant decrease in the number of mushroom spines 
(Fig. 7 A). In this set of experiments, the number of filopodia 
per 10 µm increased from 2.6 ± 0.5 to 5.0 ± 0.7 (P = 0.01; n = 12). 
The number of mushroom spines decreased from 3.5 ± 0.5 to 
1.1 ± 0.4 (P < 0.001; n = 12). In contrast, in parallel experi-
ments, the effect of miR-29b was prevented by the expression 
of mutArpc3 (Fig. 7 B). This phenotypic rescue via overexpres-
sion of an Arpc3 construct lacking in miR-29a/b target sites 
strongly suggests that down-regulation of Arpc3 is central to 
the mechanism via which these miRs modulate neuronal struc-
ture. Expression of mutArpc3 alone did not notably alter the 
dendritic phenotype (3.1 ± 0.6 filopodia and 2.7 ± 0.4 mush-
room spines per 10 µm for mutArpc3 plus miR-Scr; n = 12).
miR-29a regulates sensitivity of synaptic 
spines to neuroplastic changes
Mature and developing spines demonstrate structural plasticity 
in response to alterations in synaptic transmission. Inherent to this 
process is an initial alteration of the actin cytoskeleton (Engert and 
Bonhoeffer, 1999), which is then stabilized through the intro-
duction of novel expression of synaptic proteins (Lamprecht and 
LeDoux, 2004). Thus, short-term loss of synaptic transmission 
(P = 0.002 from untreated control). Treatment with TTx for 24 h on miR-29a antagonist neurons did not significantly reduce spine volume (25.2 ± 16.9% 
reduction; ns from untreated control). Error bars represent the mean ± SEM. (E and F) Contextual fear conditioning induces up-regulation of miR-29a/b.   
(E) Percentage of freezes measured in the conditioning context 24 h after fear conditioning. Data are expressed as the mean (±SEM) percentage of freezes. 
Statistical analysis was performed by an independent sample Student’s t test in which t = 8.10 and degrees of freedom = 10 (P < 0.001 vs. context alone). 
(F and G) Levels of miR-29a and -29b in hippocampal tissue extracted from mice that underwent contextual fear conditioning or control context exposure 
(F) and levels of Arpc3 in the same samples as F (G). Data are expressed as the mean ± SEM. Statistical analysis was performed by a one-way analysis 
of variance followed by Bonferroni’s correction for multiple comparisons. miR-29a: F(2,17) = 6.51 (P = 0.008) using a post-hoc Bonferroni’s test versus 
context alone with 45 min of conditioning (P = 0.007); miR-29b: F(2,17) = 7.33 (P = 0.005) using a post-hoc Bonferroni’s test versus context alone with   
45 min of conditioning (P = 0.005); Arpc3: F(2,18) = 9.76 (P = 0.0013) using a post-hoc Bonferroni’s test versus context alone with 45 min of conditioning 
(P < 0.01) and 2 h of conditioning (P < 0.05). (A and D–G) *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bars: (A and C) 3.5 µm; (B) 5 µm.
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such as cocaine can target genes that encode for cytoskeleton 
regulatory proteins, therefore inducing spine restructuring (Toda   
et al., 2006). Recent observations demonstrate regulation of miR 
levels in response to chronic cocaine exposure (Hollander et al., 
2010), suggesting that the miR transcriptome may be subject to 
widespread  regulation  by  psychoactive  drugs.  In  this  study,   
using an in vivo chronic drug exposure protocol, we describe 
marked changes (for 20% of 384 miRs tested) in the expres-
sion profile of rodent miRs after treatment with nicotine, co-
caine, or amphetamine. Changes observed were both region- and 
drug-specific and may therefore reflect the different cellular and 
molecular mechanisms triggered by each psychostimulant drug. 
In contrast, expression levels of miRs that were up-regulated in 
several areas and upon different treatments are therefore likely 
to be common targets of enhanced neuronal activity and/or plastic   
changes within these circuits.
To identify which of the miRs targeted by psychostimu-
lants in vivo may regulate neuronal structure, we turned to pri-
mary cultures of hippocampal neurons as a well-established 
model of synapse formation. We first investigated miR expres-
sion  changes  during  synaptogenesis.  At  this  stage,  neuronal   
activity results in synchronized Ca
2+ transients within the neuronal 
network (Fig. 2 B; Ogura et al., 1987; Bacci et al., 1999). Previous 
work has demonstrated that these network Ca
2+ signals trig-
ger intracellular cascades and regulate gene expression via   
Ca
2+-dependent transcription factors, such as CREB (Greer and 
Greenberg, 2008). In fact, it is now apparent that several genes 
involved in neuronal plasticity, e.g., Bdnf and c-Fos, are regu-
lated in an activity-dependent fashion (Greer and Greenberg, 
2008). Emerging data now suggest a role for miRs as fine-tuning 
regulators of synaptic strength and neuronal plasticity. Further-
more, as miR biogenesis (Lugli et al., 2005) and turnover (Krol 
et al., 2010) are themselves regulated by synaptic activity, multiple 
layers of regulation may be present between miRs and neuronal 
activity. For example many miR loci emerged from a wide screen-
ing of the CREB regulon (Vo et al., 2005) or showed activity de-
pendency and/or CREB-responsive elements in their proximal 
promoter (Impey et al., 2010). In this study, several miRs showed 
a marked increase between 7 and 14 DIV (Fig. 2 A). In particular, 
activity-dependent  up-regulation  was  observed  for  the  clusters 
miR-29a/b and miR-182/183. Further investigation identified a 
role for miR-29a/b in regulation of synaptic structure. Taken to-
gether, confocal imaging and electrophysiological measurements 
suggested that the effect of miR-29a/b was primarily on postsyn-
aptic spine structure rather than on synaptic transmission by itself. 
This effect was phenocopied by overexpression of specific siRNA 
against Arpc3, and, importantly, the effects on spine structure 
were not observed in neurons overexpressing recombinant Arpc3 
mutated in the miR-29a/b seed region. Therefore, our data indi-
cate that Arpc3 and hence actin dynamics are subject to activity- 
dependent regulation via the miR-29a/b cluster.
The formation and maintenance of spine structure reflect 
underlying changes in the actin cytoskeleton. Actin turnover in 
spines is itself a very rapid process, with half-life measured   
between 30 and 60 s (Star et al., 2002). This requires the con-
certed effect of numerous actin nucleation proteins, capping 
proteins, and depolymerizing factors (Hotulainen et al., 2009). 
remodeling (Fischer et al., 2004) in hippocampal circuits. Adult 
mice were first exposed to a conditioning procedure that con-
sisted in the administration of a tone for 30 s with the adminis-
tration of a 0.5 mA electrical foot shock during the last 2 s of the 
tone. This was then repeated three times in a new cage to create 
the conditioning context. When reexposed to the same context 
24 h after the conditioning procedure, mice exposed to the foot 
shocks showed significantly increased fear-conditioned freezing 
responses (P < 0.001) relative to mice exposed to the context in 
the absence of the conditioning procedure (Fig. 7 E). Alterations 
in levels of miR-29a/b in the hippocampus were then measured 
in control and conditioned animals after the contextual fear con-
ditioning. A highly significant increase in both miR-29a and 
miR-29b  (P  =  0.007  and  0.005,  respectively)  was  detected   
45 min after contextual conditioning with respect to mice sacrificed 
45 min after a simple exposure to the context. This appeared to 
be a transient response, as the enhancement was no longer sig-
nificant 2 h after conditioning (Fig. 7 F). In contrast, miR-182, 
miR-183, miR-190b, and miR-680 were not altered by this   
treatment  (unpublished  data).  Furthermore,  levels  of  Arpc3 
mRNA were significantly decreased at both 45 min (0.7 ± 0.05,   
P < 0.01) and 2 h (0.77 ± 0.02, P < 0.05) after contextual fear 
conditioning, suggesting a close temporal regulation of Arpc3 
levels by miR-29a/b (Fig. 7 G).
Discussion
Dendritic spines are discrete compartments specialized in syn-
aptic communication and are equipped with the essential ma-
chinery for protein synthesis. Local control of mRNA translation 
allows neurons to respond to extracellular cues at a subcellular 
resolution, and this accounts for the tight spatial regulation of 
synaptic strength that occurs during plasticity (Schratt, 2009). 
Recent evidence suggests that miRs are involved in the regu-
lation of gene expression at the synapse. Several miRs are en-
riched in the synaptodendritic compartment, where they fine 
tune the production of proteins that determine spine head size 
(Schratt et al., 2006; Siegel et al., 2009), regulate dendritic   
arborization (Fiore et al., 2009), or mediate synaptic plasticity 
(Rajasethupathy et al., 2009; Gao et al., 2010). In this study, we 
identify a novel miR cluster involved in the regulation of spine 
morphology and provide evidence that this may be involved in 
activity-dependent structural plasticity. miR-29a/b target Arpc3 
of the ARP2/3 actin nucleation complex, thereby reducing the 
probability of actin branch formation, a fundamental step in the 
development of a fully mature spine (Hotulainen et al., 2009). 
Interestingly, miR-29a had already been identified in a screen 
for miRs enriched in rat forebrain synaptosomes (Siegel et al., 
2009), suggesting a correlation between this miR and localized 
repression of protein translation in synaptic spines.
Psychostimulants induce activity-dependent rewiring of 
neuronal circuits and long-term neuroadaptations via synapse-
specific Hebbian plasticity, structural plasticity, and modulation 
of gene expression (Russo et al., 2010). Transcription factors 
like CREB (Walters et al., 2005), FosB (McClung and Nestler, 
2003), and NF-kB (Russo et al., 2007) are persistently activated 
after chronic treatments with psychostimulants. Notably, drugs 901 miR29a/b effect on spine morphology • Lippi et al.
screen using a real-time PCR system (7900HT Fast; Applied Biosystems). Data 
were analyzed with StatMiner software (Integromics). The 34 selected miRs 
were quantified via a custom-made real-time quantitative PCR assay on 96-well 
plates (Applied Biosystems) following the manufacturer’s recommendations. 
Samples were retrotranscribed using Megaplex Pool A primers (Applied Bio-
systems). Individual miRs were quantified via miR assays (TaqMan) following 
the manufacturer’s recommendations. Real-time PCR data were processed and 
analyzed using the comparative CT method (Livak and Schmittgen, 2001). 
The CT values were then expressed relative to the first control sample (defined 
as 1) and the mean ± SEM calculated from the separate experiments.
Imaging and analysis of dendritic structures
At  14–15  DIV,  transfected  neurons  grown  on  28-mm  coverslips  were 
mounted on the stage of a confocal microscope (LSM510; Carl Zeiss) and 
maintained at 37°C in a Krebs/Hepes buffer (KHB; 20 mM Hepes, 130 mM 
NaCl, 5.4 mM KCl, 1.0 mM MgCl2, 1.8 mM CaCl2, and 10 mM glucose, 
pH 7.4). Neurons were imaged using a 63× oil immersion lens with an 
additional 4× optical zoom applied for dendritic regions. Confocal sec-
tions of EGFP-MEM–expressing neurons were reconstructed using Volocity 
software (PerkinElmer). To avoid user bias, imaging and analysis of ex-
periments examining changes in filopodia/spine number were conducted 
blind. Structures were characterized according to the method of Hotulainen 
et al. (2009). For experiments requiring the same dendritic region to be 
imaged on consecutive days, neurons were grown in a 4-well chambered 
coverglass system (Thermo Fisher Scientific). Spine head volume was calcu-
lated from volume-rendered stacks using Volocity software.
Preparation and transfection of primary hippocampal neurons
Primary cultures of hippocampal neurons were prepared from neonatal 
C57BL6 mice (<1 d old) essentially as previously described (Young et al., 
2008). 10–30 µl droplets (containing approximately 50,000–100,000 
cells) were seeded onto polylysine-coated coverslips or multiwell plates in 
Neurobasal A medium supplemented with 2% B27, 1 µg/µl gentamycin, 
2 mM glutamax, and 5% FCS. After 24 h, this medium was supplemented 
with 5 µM arabinofuranosyl cytidine to inhibit glial cell division. After a 
further 48 h, this was replaced with fresh Neurobasal A supplemented with 
2% B27, 1 µg/µl gentamycin, and 2 mM glutamax only.
Except where otherwise indicated, 9-DIV neurons were transfected 
with 1 µg EGFP-MEM plasmid (Takara Bio Inc.) plus 10 nM miR oligonucle-
otide, 40 nM siRNA oligonucleotide, or 50 nM miR antagonist oligonucle-
otide  using  2  µl/ml  Lipofectamine2000  (Invitrogen)  according  to  the 
manufacturer’s  instructions.  For  experiments  using  plasmid  expression  of 
miRs, the miR plasmid (GeneCopoeia), which coexpresses a GFP reporter 
protein, was cotransfected with a plasmid expressing cytosolic tdTomato 
(provided by M. Schell, Uniformed Services University of the Health Sci-
ences, Bethesda, MD) at a ratio of 2:1 (total DNA was 2 µg). The tdTomato 
fluorescence was generally brighter than the GFP reporter inherent to the miR 
plasmid and so was used to identify dendritic structures. Transfections of neu-
rons with miR or siRNA oligonucleotides alone were conducted using 2.5 µl/ml 
siPORT NeoFX transfection agent (Invitrogen) and the same oligonucleo-
tide concentration described above. For experiments measuring knockdown   
of protein levels, neurons were transfected at 6 DIV and collected at 9 DIV.
Electrophysiological measurements
Electrophysiological recordings were performed on hippocampal neurons 
overexpressing miR-29a, -29b, or -Scr in cells cotransfected with EGFP-MEM 
(identified by GFP fluorescence). Cells were voltage clamped at a holding 
potential of 60mV. Patch recordings were made using an amplifier (Multi-
clamp 700B) and pCLAMP 9.2 software (Molecular Devices) sampling at   
50 kHz and filtering at 10 kHz. Patch pipettes were pulled from filamented 
borosilicate glass (with an outer diameter of 1.5 mm and an inner diameter 
of 0.86 mm; GC150F-7.5; Harvard Apparatus) with a two-stage vertical 
puller (PC-10; Narishige). Pipettes were used with a final tip resistance of   
3–4 MΩ when filled with a solution containing 90 mM K-gluconate, 20 mM 
KCl, 20 mM Hepes, 0.2 mM EGTA, 1 mM MgCl2, and 0.1 mM CaCl2; pH 
was adjusted to 7.2 with KOH. Whole-cell access resistances were <20 MΩ 
and were compensated by 70%. The composition of the bath solutions (nor-
mal artificial cerebrospinal fluid) was 125 mM NaCl, 2.5 mM KCl, 26 mM 
NaHCO3, 10 mM glucose, 1.25 mM NaH2PO4, 2 mM sodium pyruvate,   
3 mM myo-inositol, 2 mM CaCl2, 1 mM MgCl2, and 0.5 mM ascorbic acid; 
pH was 7.4 when continuously bubbled with 95% O2/5% CO2.
Real-time PCR on miR-29 targets
The level of potential miR-29a and -29b targets was assessed via Universal 
ProbeLibrary assays (TaqMan; Roche) on a LightCycler 480 system (Roche) 
following the manufacturer’s recommendations. The primers used were the 
Arpc3 belongs to the multisubunit ARP2/3 complex responsible 
for initiating branching in actin filaments (Goley and Welch, 
2006). A pioneering reconstitution study on the ARP2/3 complex 
described in detail the role of the individual subunits (Gournier 
et al., 2001). In the absence of Arpc3 (previously named p21 
subunit), the complex has no gross abnormalities, is able to cross-
link actin filaments into Y-branched arrays, and maintains the 
regulatory  sites  activated  by  exogenous  factors.  Interestingly 
though, ARP2/3 depleted of the p21 subunit exhibits reduced nu-
cleation activity (10 fold) and decreased branching frequency 
(Gournier et al., 2001). Therefore, Arpc3 appears to primarily 
have a regulatory function and represents an ideal target for fine 
tuning the activity of the complex. Here, we propose that the role 
of miR-29a/b is to modulate the activity of the ARP2/3 complex 
by targeting the regulatory subunit Arpc3 (possibly at the syn-
aptodendritic compartment, as shown in Schratt et al. [2006] and 
Siegel et al. [2009]), thus maintaining flexibility in neuronal net-
works. In addition, the up-regulation of miR-29a/b in the hippo-
campus during contextual fear learning suggests a role for these 
miRs in regulating hippocampal spine remodeling within a more 
physiological context (Leuner et al., 2003; Knafo et al., 2004; 
Restivo et al., 2009). Whether the role of these miRs is to facili-
tate the removal or redirection of existing synaptic connections or 
to instead provide a homeostatic mechanism to counteract exces-
sive positive synaptogenic stimuli remains to be determined.
The brain adapts to sensory experiences through rapid 
changes in the number and strength of synaptic connections. It 
has been recently demonstrated that only a fraction of the syn-
apses formed during development or induced by sensory experi-
ences is stably maintained throughout adult life (Yang et al., 
2009), whereas the majority undergoes a process of spine elimi-
nation. In this paper, we demonstrate that miR-29a/b target 
ARPC3 of the Arp2/3 complex, thereby decreasing the rate of 
actin branching and reducing the efficiency of neurons to drive 
dendritic spine head enlargement and synaptic consolidation. In 
light of our findings, it is conceivable that the up-regulation of miRs 
such as miR-29a/b represents an activity-dependent pathway to 
counterbalance excessive positive cues driving spine formation 
and reinforcement of synaptic communication. In support of this 
hypothesis, miR-29b levels increase steadily in vivo during the 
early stages of brain development (Hébert et al., 2008) and after 
context fear conditioning (Fig. 7 F). Therefore, the spatial and 
temporal regulation of these miRs, combined with the targeting of 
a key component of the actin remodeling process, would suggest 
a critical role for miR-29a/b in neuronal structural plasticity.
Materials and methods
Chronic drug treatment in adult mice
Chronic treatments with psychostimulants were performed as described in 
Ziviani et al. (2011). In brief, adult mice were treated with either saline,   
1 mg/kg () nicotine hydrogen (+) tartrate, 10 mg/kg cocaine hydrochlo-
ride, or 5 mg/kg d-amphetamine-d3 sulfate salt via a single i.p. injection 
once a day for 5 d. Animals were then sacrificed via decapitation, and 
brain regions were dissected on ice.
Small RNA extraction and quantification
Total RNA (including the small RNA fraction) was extracted following the 
manufacturer’s recommendations (miRNeasy kit; QIAGEN). 384-well array 
microfluidic cards (TaqMan; Applied Biosystems) were used for an initial JCB • VOLUME 194 • NUMBER 6 • 2011   902
AGTGACATTTATTATATATTACATGTTCGCTTAAAACTGCCAAAAATCGA-
AATCACCCGACACCC-3.
miR-29a sensor
To address the specificity and efficiency of miR-29 oligonucleotides (Invitro-
gen) and miR antagonists (Exiqon), we designed an miR-29a sensor. Clon-
ing was performed as described in Siegel et al. (2009). The primers used 
were miR-29a sensor forward 5-GGCCGCTAACCGATTTCAGATGGTGC-
TAACTAACCGATTTCAGATGGTGCTAT-3  and  reverse  5-CTAGATAG-
CACCATCTGAAATCGGTTAGTTAGCACCATCTGAAATCGGTTAGC-3. 
The sensor was cotransfected with EGFP-MEM into primary hippocampal 
neurons at 4 DIV and imaged after 48–72 h.
Single-cell calcium imaging
Changes in intracellular Ca
2+ were measured in hippocampal neurons   
using fura-4f–acetoxymethyl (Invitrogen). Neuronal cultures grown on 28-mm 
glass coverslips were loaded with 2 µM fura-4f–acetoxymethyl for 1 h in 
KHB. Coverslips were then mounted on the stage of an inverted epifluores-
cence microscope (Axiovert 200; Carl Zeiss) and maintained at 37°C in 
KHB. Cells were sequentially excited at 340 and 380 nm, and emission 
fluorescence was collected via a 510-nm band pass filter using a cooled 
charge-coupled device camera (Hamamatsu Photonics). Measurements of 
spontaneous network Ca
2+ transients in the presence or absence of 50 µM 
PTx were made by calculating the mean peak minus basal Ca
2+ response 
and are expressed as 340:380 ratio units.
Fear conditioning
The fear conditioning procedure was performed as described in Zanardi   
et al. (2007). In brief, raining took place in a conditioning chamber (23 × 22 
× 24 cm) with gray Plexiglas walls and ceiling. Scrambled shock was de-
livered by a shock source to a grid floor made of stainless steel bars, which 
were 2 mm in diameter and spaced 0.5 cm apart. Mice were transferred 
to the conditioning chamber, and, after an initial acclimatization period of 
2 min, were presented with three pairings of the tone with foot shock (0.5 mA 
for 2 s). The tone was presented for 30 s, and the shock was administered 
during the last 2 s of the tone. Pairings were separated by 2 min, and mice 
were removed from the chamber 30 s after the last shock presentation. Mice 
exposed to the context alone were transferred to the conditioning chamber 
for 5 min but did not receive the conditioning procedure. Approximately   
24 h after conditioning, mice were tested for contextual conditioning. Mice 
were placed into the conditioning chamber for 5 min, and freezing behavior 
was scored. Freezing was scored using a time-sampling procedure in which 
every 10 s a determination was made whether or not a mouse was freezing. 
Freezing was defined as the absence of all movement except for respiration 
for a minimum of 1 s.
Statistical analysis
Data were analyzed using an unpaired Student’s t test or a one-way analy-
sis of variance with a Tukey’s post-hoc test (Prism; GraphPad Software). 
Cumulative frequency histograms were compared using the Kolmogorov–
Smirnov test (Axon pCLAMP9; Molecular Devices).
Online supplemental material
Fig. S1. shows initial screening for miRs involved in neuroplasticity using 
TaqMan low density arrays. Fig. S2 shows that miRs are regulated in a 
similar fashion by different drugs of abuse and in different brain areas.   
Fig. S3 shows that pEZX-premiR-29b mimics the effect of oligonucleotides 
on spine morphology and that miR-29a and -29b do not prevent PTx- 
induced Ca
2+ transients in neuronal networks. Fig. S4 shows the valida-
tion of predicted miR-29a and -29b targets in primary cultures of mouse 
hippocampal neurons and characterization of the dsRed miR-29a sensor 
plasmid. Fig. S5 shows direct targeting of Arpc3 3-UTR by miR-29a and 
-29b. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.201103006/DC1.
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following: ArhGAP28, forward 5-CCGTCAGGGATGTCAGAGAC-3 and 
reverse 5-GAGTAGCATGCTCACAAGAATCA-3; ArhGAP29, forward   
5-GGATTCAGAGTCTATAAGTCCAGGAG-3 and reverse 5-ATCAGCA-
GAAGACATGGTTCC-3; ArhGEF5, forward 5-TTCATGGACCTCACA-
AAAACC-3 and reverse 5-TCCAGCGAAGCTTTTCACTT-3; Arpc3, forward 
5-GAAGGAAATGTACACGCTAGGAA-3  and  reverse  5-GAGGTACG-
CACGCATCATC-3; Bace1, forward 5-AGATGGACTGCAAGGAGACG-3 
and  reverse  5-ATGTTCCAAGGGGTCGTG-3;  Camk2b,  forward   
5-GAGGATGAAGATGCCAAAGC-3 and reverse 5-GAACTGGAGATTG-
GCAGGAG-3; Coro6, forward 5-TGGAACAGCAATGGTAGCC-3 and 
reverse 5-GTGGGCTGCAAACCTCTC-3; Daam1, forward 5-CTGGTTC-
TTCGCGCTGTC-3 and reverse 5-GGCCATGGTTGAATTCTCTC-3; Dnm3, 
forward 5-GATTCCCAGGAAGATGTGGA-3 and reverse 5-TGTCCATT-
TTCATCATTTTCAGTTA-3; Dok4, forward 5-CGTCAAGCAAGGCTAT-
GTGA-3 and reverse 5-CAGCACCTCCGGTAAATCC-3; Fez2, forward 
5-CCTCTCGGAGAAAGGGATG-3 and reverse 5-GAATGCATGTCCA-
ACTGCTC-3; Frmd4a, forward 5-CCTTCAAGCTGGATGAACAAA-3 and 
reverse 5-CTCTCGTTCCAGGCGTTC-3; Fscn1, forward 5-GCCAACGAGA-
GGAACGTG-3 and reverse 5-GGTGCGAAAGGCACACTT-3; Gmip1, 
forward  5-CGAGATATCATTGGGGAACG-3  and  reverse  5-CCAG-
GTCTTCTCTGCGTACA-3; Gprin1, forward 5-GGGTGAGAGAGTCT-
GGATGC-3 and reverse 5-TTAGGGGGCTGGAGTCCTT-3; Lasp1, for-
ward 5-TCGTCCTATGGTGGGTACAAG-3 and reverse 5-GGCAGCGC-
TGTAGTCATACAC-3; Map6d1, forward 5-AAGCCCTCAAGATCCACAAA-3 
and reverse 5-TGTGAATTTCCTCACCTCTGG-3; Ninj2, forward 5-CAG-
CAATCCTATTTGATGACTACC-3 and reverse 5-GGGAAATGCTAGTTATC-
CTGACA-3; Nrsn1, forward 5-GGGGATTGGAGGGACAGA-3 and 
reverse 5-CATCTTCCCAGCTTCAATGTT-3; Ophn1, forward 5-CCATCATC-
CGTTCGTGCT-3 and reverse 5-CCGGGAAGCTGTTTCAAAG-3; Pcdha1, 
forward 5-AAATGATGCTGGCTCTCAAAA-3 and reverse 5-CTGGACCAGC-
CCGTAGAAT-3; RapGEFL1, forward 5-GTAGCTGTTGCTTCCTCTGGA-3 
and reverse 5-ATACCCAGCGTGGTGAAAAC-3; Rgl3, forward 5-GCCGT-
GTACAGCGTCTCC-3 and reverse 5-AAGGAAGGTGTCGGTAGCC-3; 
Rhobtb, forward 5-GACACACTTGGTTGCTCTCG-3 and reverse 5-ATGCT-
CACACCACTGACAGC-3; Spna2, forward 5-CCTCAGATGAAGTGAG-
GGAGA-3 and reverse 5-CCAGCAGGGCAGTTCTCT-3; and Stau6, for-
ward 5-CAAGCCAGCACTCAAATCAG-3 and reverse 5-CGTTACTTTC-
CTTCCGTCTCC-3.
Luciferase Assay
pGL3-mmArpc3 and pGL3-hsArpc3 were obtained by amplifying the en-
tire 3-UTR of the mouse and human Arpc3 and then cloning them into 
pGL3–multiple cloning site (Promega). The primers used were as follows: 
mmArpc3 nested forward PstI 5-CTGCAGCTGCAGGAGGAGCCTGGGC-
AGCAC-3,  mmArpc3  nested  reverse  EcoRI  5-GAATTCGAATTCAAGCTT-
TTTCTCAAAAATGTTTTAATTC-3, hsArpc3 nested forward NsiI 5-ATGCATA-
TGCATAGGGAGCCCGGGCAGCCACCG-3, and hsArpc3 nested reverse 
EcoRI 5-GAATTCGAATTCTGGAATGTTAGAAATTTCTTTATTATTAC-3.
Luciferase experiments were conducted as follows: HEK-293 cells 
were  grown  on  96-well  clear-bottom  white  microplates  (Corning)  at   
20–30% confluency. After 18–24 h, miR oligonucleotides or miR antago-
nists were transfected using 0.5 µl/well siPORT. After a further 8 h, pGL3 
constructs were cotransfected with a Renilla plasmid (1:20) via Ca
2+/phos-
phate precipitation. Luciferase chemiluminescence was assessed 24–48 h 
after transfection using the Dual-Glo Luciferase Assay system (Promega) fol-
lowing  the  manufacturer’s  recommendations.  Data  were  normalized  to   
Renilla luminescence.
Western blotting
Levels of Arpc3, Arp3, and GAPDH proteins were assessed via Western 
blotting. Samples were collected in 2× loading buffer (0.125 M Tris-HCl, 
pH 6.8, 4% SDS, 20% glycerol (volume/volume), 0.003% Bromophenol 
blue, and 10% -mercaptoethanol), sonicated, and then loaded onto a 
13% polyacrylamide gel. Chemiluminescence was detected using ECL Plus 
(GE Healthcare) and analyzed using ImageJ software (National Institutes 
of Health). The antibodies used were goat anti-Arpc3 (1:1,000; Abcam), 
mouse monoclonal anti-Arp3 (1:15,000; Abcam), and mouse monoclonal 
anti-GAPDH (1:25,000; Santa Cruz Biotechnology, Inc.).
Site-directed mutagenesis
Mouse Arpc3 3-UTR was mutated using a site-directed mutagenesis kit 
(Quikchange II; Agilent Technologies) following the manufacturer’s recommen-
dations. The primers used were mArpc3 mutated forward 5-GGGTGTCG-
GGTGATTTCGATTTTTGGCAGTTTTAAGCGAACATGTAATATATAATAAA-
TGTCACTGCTTATGTTAGACATT-3 and reverse 5-AATGTCTAACATAAGC-903 miR29a/b effect on spine morphology • Lippi et al.
depolymerization  during  dendritic  spine  morphogenesis.  J.  Cell  Biol. 
185:323–339. doi:10.1083/jcb.200809046
Im, H.I., J.A. Hollander, P. Bali, and P.J. Kenny. 2010. MeCP2 controls BDNF 
expression  and  cocaine  intake  through  homeostatic  interactions  with   
microRNA-212. Nat. Neurosci. 13:1120–1127. doi:10.1038/nn.2615
Impey,  S.,  M.  Davare,  A.  Lasiek,  D.  Fortin,  H.  Ando,  O.  Varlamova,  K. 
Obrietan,  T.R.  Soderling,  R.H.  Goodman,  and  G.A.  Wayman.  2010. 
An activity-induced microRNA controls dendritic spine formation by 
regulating  Rac1-PAK  signaling.  Mol.  Cell.  Neurosci.  43:146–156. 
doi:10.1016/j.mcn.2009.10.005
Kim,  V.N.,  J.J.  Han,  and  M.C.  Siomi.  2009.  Biogenesis  of  small  RNAs  in   
animals. Nat. Rev. Mol. Cell Biol. 10:126–139. doi:10.1038/nrm2632
Knafo, S., G. Ariav, E. Barkai, and F. Libersat. 2004. Olfactory learning-induced 
increase in spine density along the apical dendrites of CA1 hippocampal 
neurons. Hippocampus. 14:819–825. doi:10.1002/hipo.10219
Korkotian, E., and M. Segal. 2001. Regulation of dendritic spine motility in cul-
tured hippocampal neurons. J. Neurosci. 21:6115–6124.
Kosik, K.S. 2006. The neuronal microRNA system. Nat. Rev. Neurosci. 7:911–
920. doi:10.1038/nrn2037
Krol,  J.,  V.  Busskamp,  I.  Markiewicz,  M.B.  Stadler,  S.  Ribi,  J.  Richter,  J.  
Duebel, S. Bicker, H.J. Fehling, D. Schübeler, et al. 2010. Characterizing 
light-regulated retinal microRNAs reveals rapid turnover as a common 
property  of  neuronal  microRNAs.  Cell.  141:618–631.  doi:10.1016/ 
j.cell.2010.03.039
Lamprecht, R., and J. LeDoux. 2004. Structural plasticity and memory. Nat. Rev. 
Neurosci. 5:45–54. doi:10.1038/nrn1301
Lee, R.C., R.L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene 
lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 
75:843–854. doi:10.1016/0092-8674(93)90529-Y
Lee, Y., K. Jeon, J.T. Lee, S. Kim, and V.N. Kim. 2002. MicroRNA maturation: 
stepwise  processing  and  subcellular  localization.  EMBO  J.  21:4663–
4670. doi:10.1093/emboj/cdf476
Leuner,  B.,  J.  Falduto,  and  T.J.  Shors.  2003.  Associative  memory  forma-
tion increases the observation of dendritic spines in the hippocampus.   
J. Neurosci. 23:659–665.
Lewis, B.P., C.B. Burge, and D.P. Bartel. 2005. Conserved seed pairing, often 
flanked  by  adenosines,  indicates  that  thousands  of  human  genes  are   
microRNA targets. Cell. 120:15–20. doi:10.1016/j.cell.2004.12.035
Lim, L.P., N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, 
D.P. Bartel, P.S. Linsley, and J.M. Johnson. 2005. Microarray analy-
sis shows that some microRNAs downregulate large numbers of target 
mRNAs. Nature. 433:769–773. doi:10.1038/nature03315
Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression 
data using real-time quantitative PCR and the 2
CT Method. Methods. 
25:402–408. doi:10.1006/meth.2001.1262
Lugli, G., J. Larson, M.E. Martone, Y. Jones, and N.R. Smalheiser. 2005. Dicer 
and eIF2c are enriched at postsynaptic densities in adult mouse brain 
and are modified by neuronal activity in a calpain-dependent manner.   
J. Neurochem. 94:896–905. doi:10.1111/j.1471-4159.2005.03224.x
McClung,  C.A.,  and  E.J.  Nestler.  2003.  Regulation  of  gene  expression  and   
cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6:1208–1215. 
doi:10.1038/nn1143
McClung, C.A., and E.J. Nestler. 2008. Neuroplasticity mediated by altered 
gene  expression.  Neuropsychopharmacology.  33:3–17.  doi:10.1038/ 
sj.npp.1301544
Miska, E.A., E. Alvarez-Saavedra, M. Townsend, A. Yoshii, N. Sestan, P. Rakic, 
M. Constantine-Paton, and H.R. Horvitz. 2004. Microarray analysis of 
microRNA expression in the developing mammalian brain. Genome Biol. 
5:R68. doi:10.1186/gb-2004-5-9-r68
Ogura, A., T. Iijima, T. Amano, and Y. Kudo. 1987. Optical monitoring of 
excitatory synaptic activity between cultured hippocampal neurons by 
a multi-site Ca2+ fluorometry. Neurosci. Lett. 78:69–74. doi:10.1016/ 
0304-3940(87)90563-5
Papa,  M.,  and  M.  Segal.  1996.  Morphological  plasticity  in  dendritic  spines 
of  cultured  hippocampal  neurons.  Neuroscience.  71:1005–1011. 
doi:10.1016/0306-4522(95)00490-4
Rajasethupathy, P., F. Fiumara, R. Sheridan, D. Betel, S.V. Puthanveettil, J.J. 
Russo,  C.  Sander,  T.  Tuschl,  and  E.  Kandel.  2009.  Characterization 
of small RNAs in Aplysia reveals a role for miR-124 in constraining 
synaptic  plasticity  through  CREB.  Neuron.  63:803–817.  doi:10.1016/ 
j.neuron.2009.05.029
Restivo, L., G. Vetere, B. Bontempi, and M. Ammassari-Teule. 2009. The forma-
tion of recent and remote memory is associated with time-dependent forma-
tion of dendritic spines in the hippocampus and anterior cingulate cortex. 
J. Neurosci. 29:8206–8214. doi:10.1523/JNEUROSCI.0966-09.2009
References
Bacci, A., C. Verderio, E. Pravettoni, and M. Matteoli. 1999. Synaptic and 
intrinsic  mechanisms  shape  synchronous  oscillations  in  hippocampal 
neurons in culture. Eur. J. Neurosci. 11:389–397. doi:10.1046/j.1460-
9568.1999.00440.x
Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. 
Cell. 116:281–297. doi:10.1016/S0092-8674(04)00045-5
Bartel,  D.P.  2009.  MicroRNAs:  target  recognition  and  regulatory  functions. 
Cell. 136:215–233. doi:10.1016/j.cell.2009.01.002
Chandrasekar,  V.,  and  J.L.  Dreyer.  2009.  microRNAs  miR-124,  let-7d  and  miR-181a   
regulate  cocaine-induced  plasticity.  Mol.  Cell.  Neurosci.  42:350–362.   
doi:10.1016/j.mcn.2009.08.009
Christensen, M., and G.M. Schratt. 2009. microRNA involvement in develop-
mental and functional aspects of the nervous system and in neurological 
diseases. Neurosci. Lett. 466:55–62. doi:10.1016/j.neulet.2009.04.043
Dillon, C., and Y. Goda. 2005. The actin cytoskeleton: integrating form and 
function at the synapse. Annu. Rev. Neurosci. 28:25–55. doi:10.1146/ 
annurev.neuro.28.061604.135757
Dunaevsky,  A.,  A.  Tashiro,  A.  Majewska,  C.  Mason,  and  R.  Yuste.  1999. 
Developmental regulation of spine motility in the mammalian central ner-
vous system. Proc. Natl. Acad. Sci. USA. 96:13438–13443. doi:10.1073/ 
pnas.96.23.13438
Edbauer, D., J.R. Neilson, K.A. Foster, C.F. Wang, D.P. Seeburg, M.N. Batterton, 
T. Tada, B.M. Dolan, P.A. Sharp, and M. Sheng. 2010. Regulation of syn-
aptic structure and function by FMRP-associated microRNAs miR-125b 
and miR-132. Neuron. 65:373–384. doi:10.1016/j.neuron.2010.01.005
Engert, F., and T. Bonhoeffer. 1999. Dendritic spine changes associated with 
hippocampal long-term synaptic plasticity. Nature. 399:66–70. doi:10 
.1038/19978
Fineberg, S.K., K.S. Kosik, and B.L. Davidson. 2009. MicroRNAs potenti-
ate neural development. Neuron. 64:303–309. doi:10.1016/j.neuron 
.2009.10.020
Fiore,  R.,  S.  Khudayberdiev,  M.  Christensen,  G.  Siegel,  S.W.  Flavell,  T.K. 
Kim, M.E. Greenberg, and G. Schratt. 2009. Mef2-mediated transcrip-
tion of the miR379-410 cluster regulates activity-dependent dendrito-
genesis by fine-tuning Pumilio2 protein levels. EMBO J. 28:697–710. 
doi:10.1038/emboj.2009.10
Fischer, M., S. Kaech, U. Wagner, H. Brinkhaus, and A. Matus. 2000. Glutamate 
receptors regulate actin-based plasticity in dendritic spines. Nat. Neurosci. 
3:887–894. doi:10.1038/78791
Fischer,  A.,  F.  Sananbenesi,  C.  Schrick,  J.  Spiess,  and  J.  Radulovic.  2004. 
Distinct roles of hippocampal de novo protein synthesis and actin re-
arrangement in extinction of contextual fear. J. Neurosci. 24:1962–1966. 
doi:10.1523/JNEUROSCI.5112-03.2004
Gao,  J.,  W.Y.  Wang,  Y.W.  Mao,  J.  Gräff,  J.S.  Guan,  L.  Pan,  G.  Mak,  D. 
Kim, S.C. Su, and L.H. Tsai. 2010. A novel pathway regulates mem-
ory  and  plasticity  via  SIRT1  and  miR-134.  Nature.  466:1105–1109. 
doi:10.1038/nature09271
Goley, E.D., and M.D. Welch. 2006. The ARP2/3 complex: an actin nuclea-
tor comes of age. Nat. Rev. Mol. Cell Biol. 7:713–726. doi:10.1038/ 
nrm2026
Gournier, H., E.D. Goley, H. Niederstrasser, T. Trinh, and M.D. Welch. 2001. 
Reconstitution of human Arp2/3 complex reveals critical roles of individ-
ual subunits in complex structure and activity. Mol. Cell. 8:1041–1052. 
doi:10.1016/S1097-2765(01)00393-8
Grabrucker, A., B. Vaida, J. Bockmann, and T.M. Boeckers. 2009. Synaptogenesis 
of hippocampal neurons in primary cell culture. Cell Tissue Res. 338:333–
341. doi:10.1007/s00441-009-0881-z
Greer, P.L., and M.E. Greenberg. 2008. From synapse to nucleus: calcium- 
dependent gene transcription in the control of synapse development and 
function. Neuron. 59:846–860. doi:10.1016/j.neuron.2008.09.002
Guo,  H.,  N.T.  Ingolia,  J.S.  Weissman,  and  D.P.  Bartel.  2010.  Mammalian   
microRNAs predominantly act to decrease target mRNA levels. Nature. 
466:835–840. doi:10.1038/nature09267
Hébert, S.S., K. Horré, L. Nicolaï, A.S. Papadopoulou, W. Mandemakers, A.N. 
Silahtaroglu, S. Kauppinen, A. Delacourte, and B. De Strooper. 2008. 
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease 
correlates with increased BACE1/beta-secretase expression. Proc. Natl. 
Acad. Sci. USA. 105:6415–6420. doi:10.1073/pnas.0710263105
Hollander, J.A., H.I. Im, A.L. Amelio, J. Kocerha, P. Bali, Q. Lu, D. Willoughby, 
C. Wahlestedt, M.D. Conkright, and P.J. Kenny. 2010. Striatal microRNA 
controls cocaine intake through CREB signalling. Nature. 466:197–202. 
doi:10.1038/nature09202
Hotulainen, P., O. Llano, S. Smirnov, K. Tanhuanpää, J. Faix, C. Rivera, and 
P. Lappalainen. 2009. Defining mechanisms of actin polymerization and JCB • VOLUME 194 • NUMBER 6 • 2011   904
Richards, D.A., J.M. Mateos, S. Hugel, V. de Paola, P. Caroni, B.H. Gähwiler, 
and R.A. McKinney. 2005. Glutamate induces the rapid formation of 
spine head protrusions in hippocampal slice cultures. Proc. Natl. Acad. 
Sci. USA. 102:6166–6171. doi:10.1073/pnas.0501881102
Robinson, T.E., and B. Kolb. 2004. Structural plasticity associated with ex-
posure  to  drugs  of  abuse.  Neuropharmacology.  47(Suppl  1):33–46. 
doi:10.1016/j.neuropharm.2004.06.025
Russo,  S.J.,  C.A.  Bolanos,  D.E.  Theobald,  N.A.  DeCarolis,  W.  Renthal,  A. 
Kumar, C.A. Winstanley, N.E. Renthal, M.D. Wiley, D.W. Self, et al. 
2007. IRS2-Akt pathway in midbrain dopamine neurons regulates be-
havioral  and  cellular  responses  to  opiates.  Nat.  Neurosci.  10:93–99. 
doi:10.1038/nn1812
Russo, S.J., D.M. Dietz, D. Dumitriu, J.H. Morrison, R.C. Malenka, and E.J. 
Nestler. 2010. The addicted synapse: mechanisms of synaptic and struc-
tural  plasticity  in  nucleus  accumbens.  Trends  Neurosci.  33:267–276. 
doi:10.1016/j.tins.2010.02.002
Saneyoshi, T., D.A. Fortin, and T.R. Soderling. 2010. Regulation of spine and 
synapse formation by activity-dependent intracellular signaling pathways. 
Curr. Opin. Neurobiol. 20:108–115. doi:10.1016/j.conb.2009.09.013
Schratt, G. 2009. microRNAs at the synapse. Nat. Rev. Neurosci. 10:842–849. 
doi:10.1038/nrn2763
Schratt, G.M., F. Tuebing, E.A. Nigh, C.G. Kane, M.E. Sabatini, M. Kiebler, and 
M.E. Greenberg. 2006. A brain-specific microRNA regulates dendritic 
spine development. Nature. 439:283–289. doi:10.1038/nature04367
Sempere,  L.F.,  S.  Freemantle,  I.  Pitha-Rowe,  E.  Moss,  E.  Dmitrovsky,  and 
V.  Ambros.  2004.  Expression  profiling  of  mammalian  microRNAs 
uncovers a subset of brain-expressed microRNAs with possible roles 
in  murine  and  human  neuronal  differentiation.  Genome  Biol.  5:R13. 
doi:10.1186/gb-2004-5-3-r13
Siegel, G., G. Obernosterer, R. Fiore, M. Oehmen, S. Bicker, M. Christensen, 
S. Khudayberdiev, P.F. Leuschner, C.J.L. Busch, C. Kane, et al. 2009. A 
functional screen implicates microRNA-138-dependent regulation of the 
depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat. 
Cell Biol. 11:705–716. doi:10.1038/ncb1876
Star, E.N., D.J. Kwiatkowski, and V.N. Murthy. 2002. Rapid turnover of actin in 
dendritic spines and its regulation by activity. Nat. Neurosci. 5:239–246. 
doi:10.1038/nn811
Tang,  J.,  and  J.A.  Dani.  2009.  Dopamine  enables  in  vivo  synaptic  plastic-
ity  associated  with  the  addictive  drug  nicotine.  Neuron.  63:673–682. 
doi:10.1016/j.neuron.2009.07.025
Toda, S., H.W. Shen, J. Peters, S. Cagle, and P.W. Kalivas. 2006. Cocaine in-
creases actin cycling: effects in the reinstatement model of drug seeking. 
J. Neurosci. 26:1579–1587. doi:10.1523/JNEUROSCI.4132-05.2006
Vo, N., M.E. Klein, O. Varlamova, D.M. Keller, T. Yamamoto, R.H. Goodman, 
and S. Impey. 2005. A cAMP-response element binding protein-induced 
microRNA  regulates  neuronal  morphogenesis.  Proc.  Natl.  Acad.  Sci. 
USA. 102:16426–16431. doi:10.1073/pnas.0508448102
Walters, C.L., J.N. Cleck, Y.-C. Kuo, and J.A. Blendy. 2005. -Opioid receptor 
and CREB activation are required for nicotine reward. Neuron. 46:933–
943. doi:10.1016/j.neuron.2005.05.005
Wayman, G.A., M. Davare, H. Ando, D. Fortin, O. Varlamova, H.Y. Cheng, 
D. Marks, K. Obrietan, T.R. Soderling, R.H. Goodman, and S. Impey. 
2008. An activity-regulated microRNA controls dendritic plasticity by 
down-regulating p250GAP. Proc. Natl. Acad. Sci. USA. 105:9093–9098. 
doi:10.1073/pnas.0803072105
West,  A.E.,  E.C.  Griffith,  and  M.E.  Greenberg.  2002.  Regulation  of  tran-
scription factors by neuronal activity. Nat. Rev. Neurosci. 3:921–931. 
doi:10.1038/nrn987
Wightman, B., I. Ha, and G. Ruvkun. 1993. Posttranscriptional regulation of the 
heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in 
C. elegans. Cell. 75:855–862. doi:10.1016/0092-8674(93)90530-4
Winter, J., S. Jung, S. Keller, R.I. Gregory, and S. Diederichs. 2009. Many roads 
to maturity: microRNA biogenesis pathways and their regulation. Nat. 
Cell Biol. 11:228–234. doi:10.1038/ncb0309-228
Yang, G., F. Pan, and W.-B. Gan. 2009. Stably maintained dendritic spines are 
associated with lifelong memories. Nature. 462:920–924. doi:10.1038/ 
nature08577
Young, K.W., E.T.W. Bampton, L. Pinòn, D. Bano, and P. Nicotera. 2008. 
Mitochondrial Ca
2+ signalling in hippocampal neurons. Cell Calcium. 
43:296–306. doi:10.1016/j.ceca.2007.06.007
Zanardi, A., R. Ferrari, G. Leo, U. Maskos, J.P. Changeux, and M. Zoli. 2007. 
Loss of high-affinity nicotinic receptors increases the vulnerability to ex-
citotoxic lesion and decreases the positive effects of an enriched environ-
ment. FASEB J. 21:4028–4037. doi:10.1096/fj.07-8260com
Ziviani, E., G. Lippi, D. Bano, E. Munarriz, S. Guiducci, M. Zoli, K.W. Young, 
and P. Nicotera. 2011. Ryanodine receptor-2 upregulation and nicotine-
mediated plasticity. EMBO J. 30:194–204. doi:10.1038/emboj.2010.279